AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2015
Oct 7, 2015
34152_dirs_2015-10-07_febae9a5-9eb0-4f40-8a37-df1560e66a4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2015-10-05
Reporting Person: Johnson Wendy S. (Director, Interim Chief Operating Office)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-05 | Common Stock | P | 1000 | $4.427 | Acquired | 1000 | Direct |
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23